1. Wang, Haibo, Yang, Wenjing, Qin, Qiong, Zhang, Zhongtao, He, Junqi. 2022. E3 ubiquitin ligase MAGI3 degrades c-Myc and acts as a predictor for chemotherapy response in colorectal cancer. In Molecular cancer, 21, 151. doi:10.1186/s12943-022-01622-9. https://pubmed.ncbi.nlm.nih.gov/35864508/
2. Ma, Qian, Zhang, Yan, Meng, Ran, Zhao, Ji Zong, He, Jun Qi. . MAGI3 Suppresses Glioma Cell Proliferation via Upregulation of PTEN Expression. In Biomedical and environmental sciences : BES, 28, 502-9. doi:10.3967/bes2015.072. https://pubmed.ncbi.nlm.nih.gov/26248734/
3. Ma, Qian, Yang, Ying, Feng, Duiping, Jiang, Wen G, He, Junqi. . MAGI3 negatively regulates Wnt/β-catenin signaling and suppresses malignant phenotypes of glioma cells. In Oncotarget, 6, 35851-65. doi:10.18632/oncotarget.5323. https://pubmed.ncbi.nlm.nih.gov/26452219/
4. Ni, Thomas K, Kuperwasser, Charlotte. 2016. Premature polyadenylation of MAGI3 produces a dominantly-acting oncogene in human breast cancer. In eLife, 5, . doi:10.7554/eLife.14730. https://pubmed.ncbi.nlm.nih.gov/27205883/
5. Norén, Elisabeth, Almer, Sven, Söderman, Jan. 2017. Genetic variation and expression levels of tight junction genes identifies association between MAGI3 and inflammatory bowel disease. In BMC gastroenterology, 17, 68. doi:10.1186/s12876-017-0620-y. https://pubmed.ncbi.nlm.nih.gov/28545409/
智鼠故事 
